These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9015273)

  • 1. Molecular characteristics of Junin virus.
    Bushar G; Sagripanti JL
    J Virol Methods; 1997 Jan; 63(1-2):27-35. PubMed ID: 9015273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cell fusion in Junin virus-infected cells by sera from Argentine hemorrhagic fever patients.
    Castilla V; Contigiani M; Mersich SE
    J Clin Virol; 2005 Apr; 32(4):286-8. PubMed ID: 15780806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of viral glycoproteins by glycosidic digestion inside a polyacrylamide gel.
    Grutadauria S; Castilla V; Zapata M; Mersich S
    J Virol Methods; 1999 Jul; 80(2):217-21. PubMed ID: 10471032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and expression of viral antigens in Vero cells persistently infected with Junin virus.
    Ellenberg P; Edreira M; Lozano M; Scolaro L
    Arch Virol; 2002 Aug; 147(8):1543-57. PubMed ID: 12181674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular processing and transport of Junin virus glycoproteins influences virion infectivity.
    Damonte EB; Mersich SE; Candurra NA
    Virus Res; 1994 Dec; 34(3):317-26. PubMed ID: 7856317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epistastic Interactions within the Junín Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1 Vaccine.
    York J; Nunberg JH
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The entry of Junin virus into Vero cells.
    Castilla V; Mersich SE; Candurra NA; Damonte EB
    Arch Virol; 1994; 136(3-4):363-74. PubMed ID: 8031239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication.
    Castilla V; Larzábal M; Sgalippa NA; Wachsman MB; Coto CE
    Antiviral Res; 2005 Nov; 68(2):88-95. PubMed ID: 16171877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of Junin virus multiplication by caffeine].
    Candurra NA; Damonte EB
    Rev Argent Microbiol; 1999; 31(3):135-41. PubMed ID: 10509392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the cytoskeleton in Junin virus multiplication.
    Candurra NA; Lago MJ; Maskin L; Damonte EB
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():147-156. PubMed ID: 9934697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superinfection exclusion is absent during acute Junin virus infection of Vero and A549 cells.
    Gaudin R; Kirchhausen T
    Sci Rep; 2015 Nov; 5():15990. PubMed ID: 26549784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristic acid analogs are inhibitors of Junin virus replication.
    Cordo SM; Candurra NA; Damonte EB
    Microbes Infect; 1999 Jul; 1(8):609-14. PubMed ID: 10611737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhibitors of the intracellular exocytic pathway on glycoprotein processing and maturation of Junin virus.
    Candurra NA; Damonte EB
    Arch Virol; 1997; 142(11):2179-93. PubMed ID: 9672585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence] of enzymatic treatment on Junin virus--Vero cells interaction].
    Raiger Iustman LJ; Candurra N; Mersich SE
    Rev Argent Microbiol; 1995; 27(1):28-32. PubMed ID: 7568866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic features of attenuated Junín virus vaccine strain candidate.
    Goñi SE; Iserte JA; Ambrosio AM; Romanowski V; Ghiringhelli PD; Lozano ME
    Virus Genes; 2006 Feb; 32(1):37-41. PubMed ID: 16525733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-pH-induced fusion of Vero cells infected with Junin virus.
    Castilla V; Mersich SE
    Arch Virol; 1996; 141(7):1307-17. PubMed ID: 8774689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to superinfection of Vero cells persistently infected with Junin virus.
    Ellenberg P; Edreira M; Scolaro L
    Arch Virol; 2004 Mar; 149(3):507-22. PubMed ID: 14991440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of vacuolar proton ATPase in Junin virus multiplication.
    Castilla V; Palermo LM; Coto CE
    Arch Virol; 2001; 146(2):251-63. PubMed ID: 11315636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of reducing, oxidizing and alkylating agents on early steps of Junin virus multiplication.
    Raiger Iustman LJ; Castilla V; Meich V; Mersich SE
    Arch Virol; 1998; 143(7):1425-32. PubMed ID: 9722885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycoprotein precursor gene of the attenuated Junin virus vaccine strain (Candid #1).
    Ghiringhelli PD; Albarino CG; Piboul M; Romanowski V
    Am J Trop Med Hyg; 1997 Feb; 56(2):216-25. PubMed ID: 9080883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.